Recently Viewed
empty-cart

There are no Recent Items

Close
Login/Register

Close
Single User License Price USD 125
Single User License Price INR 9154
Corporate User License Price USD 375
Corporate User License Price INR 27461
Site License Price USD 250
Site License Price INR 18308
Request a Quote

Report Title

Genovis AB (GENO) - Financial and Strategic SWOT Analysis Review

Quote Request for License Type
License Type Price  
Single User License USD 125
Site License USD 250
Enterprise Wide License USD 375
"Thanks for submitting the form. Our marketing team will connect back to you for the budget constraint."
Close
REQUEST A CUSTOMIZED RESEARCH

Report Title

Genovis AB (GENO) - Financial and Strategic SWOT Analysis Review


Quote Request for License Type
License Type Price  
Single User License USD 125
"Thanks for letting us know your requirement. Our research team will connect back to you for the bespoke requirement."
Close
REQUEST FOR SAMPLE REPORT

Report Title

Genovis AB (GENO) - Financial and Strategic SWOT Analysis Review

"Thanks for submitting the form. The concerned team will send the sample report in the next 12 hours."
"Thank you for downloading the sample report."
Close

Genovis AB (GENO) - Financial and Strategic SWOT Analysis Review



Executive Summary

Genovis AB (GENO)-Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company's businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company's key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

- Business description-A detailed description of the company's operations and business divisions.

- Corporate strategy-Analyst's summarization of the company's business strategy.

- SWOT Analysis-A detailed analysis of the company's strengths, weakness, opportunities and threats.

- Company history-Progression of key events associated with the company.

- Major products and services-A list of major products, services and brands of the company.

- Key competitors-A list of key competitors to the company.

- Key employees-A list of the key executives of the company.

- Executive biographies-A brief summary of the executives' employment history.

- Key operational heads-A list of personnel heading key departments/functions.

- Important locations and subsidiaries-A list and contact details of key locations and subsidiaries of the company.

- Key manufacturing facilities-A list of key manufacturing facilities of the company.

- Detailed financial ratios for the past five years-The latest financial ratios derived from the annual financial statements published by the company with 5 years history.

- Interim ratios for the last five interim periods-The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Genovis AB (Genovis) develops, produces and markets enzyme products, which facilitate the development and quality control of biological drugs. The company's products are used for antibody molecules analysis to identify and characterize proteins, antibody based biotherapeutics; monoclonal antibodies, antibody drug conjugates and biosimilars. Its SmartEnzymes product portfolio encompasses FabRICATOR (IdeS), GingisKHAN (KGP), FabULOUS (SpeB), GlycINATOR (EndoS49), FabRICATOR Z (IdeZ), GingisREX (Rgp) and IgGZERO (EndoS). Genovis also offers antibody fragmentation services for different species and subclasses of Immunoglobulin G antibodies. The company offers its products to medical device, pharmaceutical and biotechnology sectors as well as contract manufacturing companies. It has presence in Massachusetts, the US; Europe and other countries. Genovis is headquartered in Lund, Sweden.

Genovis AB Key Recent Developments

May 15,2018: Genovis: Interim Report January-March 2018

Apr 26,2018: Genovis launches GlycOCATCH for purification of O-glycosylated proteins

Apr 24,2018: Genovis Appoints Kevin Cook as Senior Application & Market Area Manager for the subsidiary Genovis Inc.

Apr 23,2018: Proposal to expand the Genovis Board of Directors at 2018 Annual General Meeting

Apr 06,2018: Genovis signs distribution agreement for South Korean market

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors' business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.

- The company's core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.

- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies' strategic, financial and operational performance.

- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.

- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

Table of Contents

Table of Contents 3

List of Tables 5

List of Figures 5

Section 1-About the Company 6

Genovis AB-Key Facts 6

Genovis AB-Key Employees 7

Genovis AB-Key Employee Biographies 8

Genovis AB-Key Operational Employees 9

Genovis AB-Major Products and Services 10

Genovis AB-History 11

Genovis AB-Company Statement 14

Genovis AB-Locations And Subsidiaries 15

Head Office 15

Other Locations & Subsidiaries 15

Section 2-Company Analysis 16

Company Overview 16

Genovis AB-Business Description 17

Genovis AB-Corporate Strategy 18

Genovis AB-SWOT Analysis 19

SWOT Analysis-Overview 19

Genovis AB-Strengths 19

Genovis AB-Weaknesses 20

Genovis AB-Opportunities 21

Genovis AB-Threats 22

Genovis AB-Key Competitors 23

Section 3-Company Financial Ratios 24

Financial Ratios-Capital Market Ratios 24

Financial Ratios-Annual Ratios 25

Performance Chart 27

Financial Performance 27

Financial Ratios-Interim Ratios 28

Financial Ratios-Ratio Charts 29

Section 4-Company's Lifesciences Financial Deals and Alliances 30

Genovis AB, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 30

Genovis AB, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018 31

Genovis AB, Recent Deals Summary 32

Section 5-Company's Recent Developments 33

May 15, 2018: Genovis: Interim Report January-March 2018 33

Apr 26, 2018: Genovis launches GlycOCATCH for purification of O-glycosylated proteins 35

Apr 23, 2018: Proposal to expand the Genovis Board of Directors at 2018 Annual General Meeting 36

Apr 06, 2018: Genovis signs distribution agreement for South Korean market 37

Dec 08, 2017: Genovis Signs Distribution Agreement in India 38

Nov 27, 2017: Genovis Announces Interim Report January-September 2017 39

May 30, 2017: Genovis expands its product portfolio and launches three products for glycan analysis 40

May 02, 2017: Genovis expands its product portfolio and launches FabALACTICA 41

Feb 27, 2017: Genovis Announces Year-End Report January-December 2016 42

Section 6-Appendix 48

Methodology 48

Ratio Definitions 48

About GlobalData 52

Contact Us 52

Disclaimer 52

To know more information on Purchase by Section, please send a mail to sales@kenresearch.com

List of Figures

Genovis AB, Performance Chart (2013-2017) 27

Genovis AB, Ratio Charts 29

Genovis AB, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 30

Genovis AB, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 31

List of Tables

Genovis AB, Key Facts 6

Genovis AB, Key Employees 7

Genovis AB, Key Employee Biographies 8

Genovis AB, Key Operational Employees 9

Genovis AB, Major Products and Services 10

Genovis AB, History 11

Genovis AB, Subsidiaries 15

Genovis AB, Key Competitors 23

Genovis AB, Ratios based on current share price 24

Genovis AB, Annual Ratios 25

Genovis AB, Annual Ratios (Cont...1) 26

Genovis AB, Interim Ratios 28

Genovis AB, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 30

Genovis AB, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018 31

Genovis AB, Recent Deals Summary 32

Currency Codes 48

Capital Market Ratios 48

Equity Ratios 49

Profitability Ratios 49

Cost Ratios 50

Liquidity Ratios 50

Leverage Ratios 51

Efficiency Ratios 51

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Thermo Fisher Scientific Inc

ProZyme Inc

New England Biolabs Inc

GE Healthcare AB

Bio-Rad Laboratories Inc

Genovis AB, SWOT analysis, SWOT, Strengths, Weaknesses, Opportunities, Threats, Corporate Strategy, Key Ratios, Share Data, Performance, Financial Performance, Overview, Business Description, Major Product, Brands, History,Key Employees, Key Operational Heads, Strategy, Key Competitors, Company Statement, Capital Market Ratios, Financial Ratios, Annual Ratios, Interim Ratios, Ratio Charts


Related Products in vertical
red-whiteline

RECENT VIEWED REPORTS



Sign up for newsletter

Close
Apply For Job

  • Applicant Name
  • Job Function
  • Total Experience
  • Skills
  • Email ID
  • Notice Period
  • Current CTC & Expected CTC
  • Phone Number
  • Validation
  • captcha  info-icon

    If validation code does not match, please refresh the page.

  • "Your resume has been successfully received. HR will connect you within 14 days in case your resume gets shortlisted."
Close
Download Company Brochure

  • Name
  • Email
  • Company Name
  • Select Country*
  • Phone Number
  • Validation
  •   info-icon

    If validation code does not match, please refresh the page.

Close
Engage With Us

  • Name
  • Designation
  • Email
  • Phone No.
  • Company Name
  • Company URL
  • Select Country*
  • Requirements/ Comments
  • Validation
  • captcha  info-icon

    If validation code does not match, please refresh the page.

  • "Thanks for submitting the form. The concerned team will respond to your query in the next 8-12 hours"
Close

Compare

Expand